ArticleInternational journal of women's health2025
Causal Effects of Endometriosis Stages on Adverse Pregnancy and Perinatal Outcomes: A Mendelian Randomization Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This mendelian randomization (MR) study aimed to investigate whether endometriosis, overall and stratified by stage (I/II vs III/IV), confers causal effects on adverse pregnancy and perinatal outcomes. Methods: Exposure data came from FinnGen for ASRM-staged endometriosis (stage I/II and III/IV) and the largest cross-ancestry GWAS meta-analysis of endometriosis, while 12 adverse pregnancy outcomes from FinnGen or GWAS catalog were defined by ICD codes. The inverse variance weighted (IVW) method was used for primary estimates, and sensitivity analyses including heterogeneity tests, horizontal pleiotropy tests, and leave-one-out analyses were performed using R packages. Results: The IVW analysis revealed that endometriosis was causally associated with an increased risk of intrahepatic cholestasis of pregnancy (ICP) [odds ratio (OR) 1.29, 95% confidence interval (CI) 1.01-1.64, p = 0.045] and premature rupture of membranes [OR 1.14, 95% CI 1.01-1.29, p = 0.028]. The advanced stages of endometriosis (III-IV) (OR 1.24, 95% CI 1.06-1.44, p = 0.006) play a more prominent role in increasing the risk of ICP compared to early stages (I-II) (OR 1.16, 95% CI 0.94-1.43, p = 0.159). However, no significant causal relationships were found between endometriosis and other adverse pregnancy outcomes. Sensitivity analyses indicated most results were robust without pleiotropy (p>0.05), except for significant heterogeneity in premature separation of placenta across stages and potential horizontal pleiotropy in gestational hypertension. Conclusion: Our findings suggest stage III/IV endometriosis as an independent causal factor for ICP, necessitating intensified hepatobiliary function monitoring in these patients. The lack of causal association between endometriosis and other obstetric complications highlights the multifactorial nature of adverse pregnancy outcomes. Future multicenter studies should explore biomarkers reflecting endometriosis-associated hepatobiliary dysfunction to guide targeted interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.